SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: chirodoc who wrote (2519)9/18/1997 11:30:00 PM
From: Andrew H   of 9719
 
>>i would think that the better the company--the more likely the risk will be in selling before fully valued.<<

Perhaps, depends on how the bios as a group hold up. I am not suggesting a lot of buying and selling, but just to keep an eye on seasonal factors. Also, if there is a winter correction this coming year like there was last year, it may be a good buying op for stocks like INCY, AFFX, AVIR, that have had a big runup and are expensive now. Also bios tend to drop when there is no news for a long period.

>>do you promise to give us all a few weeks warning before the biggest peaks and valleys?--come on, you can do it!<<

Right. Tell you what, If you figure out a way to give me long distance alignments over the Rockies, I'll give you all a few week warning. Deal?

Believe me, when I think something is going to happen, I will post. First thing to watch will be after the H and Q conference in January--there is often a biotech correction that goes from then until May. But we all know there is big danger in trying to time the market.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext